154 related articles for article (PubMed ID: 27277572)
21. [Genotype and function analyses of four inherited dysfibrinogenemia pedigree caused by Arg16 amino acid substitution in fibrinogen Aα chain].
Jiang LL; Wang XF; Ding QL; Xu GQ; Zhang LW; Dai J; Lu YL; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):475-9. PubMed ID: 22967385
[TBL] [Abstract][Full Text] [Related]
22. Recurrent VTE in a heterozygote of the fibrinogen Aα IVS4+1G>T and Aα p.Arg168Ter mutation.
Berens C; Rühl H; Ivaškevičius V; Oldenburg J; Hertfelder HJ; Pötzsch B
Thromb Haemost; 2016 May; 115(5):1073-5. PubMed ID: 26763372
[No Abstract] [Full Text] [Related]
23. Two novel mutations in the fibrinogen γ nodule.
Kotlín R; Pastva O; Stikarová J; Hlaváčková A; Suttnar J; Chrastinová L; Riedel T; Salaj P; Dyr JE
Thromb Res; 2014 Oct; 134(4):901-8. PubMed ID: 25074738
[TBL] [Abstract][Full Text] [Related]
24. Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 Val --> Asp).
Brennan SO; Hammonds B; George PM
J Clin Invest; 1995 Dec; 96(6):2854-8. PubMed ID: 8675656
[TBL] [Abstract][Full Text] [Related]
25. Familial hypofibrinogenaemia associated with heterozygous substitution of a conserved arginine residue; Bbeta255 Arg-->His (Fibrinogen Merivale).
Maghzal GJ; Brennan SO; Fellowes AP; Spearing R; George PM
Biochim Biophys Acta; 2003 Feb; 1645(2):146-51. PubMed ID: 12573244
[TBL] [Abstract][Full Text] [Related]
26. Heterozygous variant fibrinogen γA289V (Kanazawa III) was confirmed as hypodysfibrinogenemia by plasma and recombinant fibrinogens.
Kaido T; Yoda M; Kamijo T; Taira C; Higuchi Y; Okumura N
Int J Lab Hematol; 2020 Apr; 42(2):190-197. PubMed ID: 31957968
[TBL] [Abstract][Full Text] [Related]
27. Analysis of Iranian patients allowed the identification of the first truncating mutation in the fibrinogen Bbeta-chain gene causing afibrinogenemia.
Asselta R; Spena S; Duga S; Peyvandi F; Malcovati M; Mannucci PM; Tenchini ML
Haematologica; 2002 Aug; 87(8):855-9. PubMed ID: 12161363
[TBL] [Abstract][Full Text] [Related]
28. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
Yan J; Luo M; Cheng P; Liao L; Deng X; Deng D; Lin F
Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517
[TBL] [Abstract][Full Text] [Related]
29. Paris I dysfibrinogenemia: a point mutation in intron 8 results in insertion of a 15 amino acid sequence in the fibrinogen gamma-chain.
Rosenberg JB; Newman PJ; Mosesson MW; Guillin MC; Amrani DL
Thromb Haemost; 1993 Mar; 69(3):217-20. PubMed ID: 8470043
[TBL] [Abstract][Full Text] [Related]
30. Novel FGG variant (γ339C→S) confirms importance of the γ326-339 disulphide bond for plasma expression of newly synthesised fibrinogen.
Brennan SO; Laurie A; Smith M
Thromb Haemost; 2015 Apr; 113(4):903-5. PubMed ID: 25588350
[No Abstract] [Full Text] [Related]
31. Abnormal fibrinogen Zlín (γThr21Ile) with missense mutation causing hypofibrinogenemia.
Riedelová-Reicheltová Z; Riedel T; Májek P; Kotlin R; Geierová V; Suttnar J; Dyr JE
Acta Haematol; 2014; 132(2):140-3. PubMed ID: 24556703
[No Abstract] [Full Text] [Related]
32. Substitution (γ335Trp→Arg) in fibrinogen Fremantle causes diminished γ chain expression and increased sialic acid content.
Brennan SO; Davis RL
Thromb Haemost; 2010 Dec; 104(6):1274-6. PubMed ID: 20838743
[No Abstract] [Full Text] [Related]
33. Congenital hypofibrinogenemia associated with novel homozygous fibrinogen Aα and heterozygous Bβ chain mutations.
Castaman G; Rimoldi V; Giacomelli SH; Duga S
Thromb Res; 2015 Jul; 136(1):144-7. PubMed ID: 25981141
[TBL] [Abstract][Full Text] [Related]
34. Fibrinogen Philadelphia, a hypodysfibrinogenemia characterized by abnormal polymerization and fibrinogen hypercatabolism due to gamma S378P mutation.
Keller MA; Martinez J; Baradet TC; Nagaswami C; Chernysh IN; Borowski MK; Surrey S; Weisel JW
Blood; 2005 Apr; 105(8):3162-8. PubMed ID: 15632207
[TBL] [Abstract][Full Text] [Related]
35. Congenital hypofibrinogenemia associated with novel heterozygous fibrinogen Bbeta and gamma chain mutations.
Castaman G; Giacomelli SH; Duga S; Rodeghiero F
Haemophilia; 2008 May; 14(3):630-3. PubMed ID: 18393984
[No Abstract] [Full Text] [Related]
36. Fibrinogen Claro--another dysfunctional fibrinogen variant with gamma 275 arginine-->histidine substitution.
Steinmann C; Jungo M; Beck EA; Lämmle B; Furlan M
Thromb Res; 1996 Jan; 81(1):145-50. PubMed ID: 8747529
[No Abstract] [Full Text] [Related]
37. Thrombosis-associated hypofibrinogenemia: novel abnormal fibrinogen variant FGG c.8G>A with oxidative posttranslational modifications.
Ceznerová E; Kaufmanová J; Stikarová J; Pastva O; Loužil J; Chrastinová L; Suttnar J; Kotlín R; Dyr JE
Blood Coagul Fibrinolysis; 2022 Jun; 33(4):228-237. PubMed ID: 35067535
[TBL] [Abstract][Full Text] [Related]
38. Congenital afibrinogenemia: Identification and characterization of two novel homozygous fibrinogen Aα and Bβ chain mutations in two Tunisian families.
Amri Y; Toumi Nel H; Hadj Fredj S; de Moerloose P
Thromb Res; 2016 Jul; 143():11-6. PubMed ID: 27164460
[TBL] [Abstract][Full Text] [Related]
39. Novel fibrinogen mutation (gamma 313 Ser-->Asn) associated with hypofibrinogenemia in two unrelated families.
Meyer M; Bergmann F; Brennan SO
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):63-7. PubMed ID: 16607083
[TBL] [Abstract][Full Text] [Related]
40. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions.
Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST
Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
